摘要通过长期的医疗实践,人们逐渐形成了以个人临床经验和推断为基础的认识方式,以及病理生理学实验或临床指标检测和评估的传统医学模式。近年来,随着各种临床流行病学的深入开展及临床科研方法的重大发展,循证医学(evidence based medicine,EBM)正在逐渐深入医学的各个领域,而心血管领域疾病的治疗也是如此,
6The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction[J]. N Engl J Med, 1989; 321:406-412
7The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and LipidLowering Treatment to Prevent
8Sever PS, DahlofB, Poulter NB, Wedel H, Beevers G,Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensiv
9Furberg CD, Bruce M, Jeffrey V. Nifedipine Dose-Related Increase in Mortality in Patients With Coronary Heart Disease[J].Circulation, 1995; 92:1 326-1 331
10Echt DS,,Liebson PR,Mitchell B,et al.Mortality in patients receiving encainide,flecainide or pi-acebo:The Cardiac Arrhythmia Suppresion Trial[].The New England Journal of Medicine.1991
